China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,702 | -10,750 | -19,278 | -9,183 | -15,406 |
| Depreciation Amortization | 2,929 | 3,259 | 3,291 | 3,078 | 3,599 |
| Income taxes - deferred | N/A | 68 | 123 | 308 | 60 |
| Accounts receivable | -479 | 99 | 51 | -1,098 | -2,512 |
| Accounts payable and accrued liabilities | 715 | 422 | -1,625 | 1,193 | 765 |
| Other Working Capital | 1,110 | 1,267 | 1,009 | 3,644 | 2,904 |
| Other Operating Activity | 17,035 | 7,517 | 17,270 | 4,953 | 13,940 |
| Operating Cash Flow | $608 | $1,882 | $841 | $2,896 | $3,350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -136 | -51 | -137 | -193 | -685 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,634 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,210 |
| Investing Cash Flow | $-136 | $-51 | $-137 | $-193 | $-1,896 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 692 | N/A | N/A | N/A | N/A |
| Debt Repayment | -2,420 | -2,264 | -1,480 | -1,505 | N/A |
| Other Financing Activity | 0 | 287 | 0 | -4,516 | 0 |
| Financing Cash Flow | $-1,729 | $-1,977 | $-1,480 | $-6,021 | $N/A |
| Exchange Rate Effect | -19 | -134 | 140 | -264 | -501 |
| Beginning Cash Position | 2,461 | 2,740 | 2,666 | 6,249 | 5,296 |
| End Cash Position | 1,185 | 2,461 | 2,030 | 2,666 | 6,249 |
| Net Cash Flow | $-1,276 | $-280 | $-636 | $-3,583 | $953 |
| Free Cash Flow | |||||
| Operating Cash Flow | 608 | 1,882 | 841 | 2,896 | 3,350 |
| Capital Expenditure | -136 | -51 | -137 | -193 | -685 |
| Free Cash Flow | 472 | 1,831 | 705 | 2,702 | 2,665 |